News
Press Release: Istari Oncology Presents Data from Phase 1 Melanoma Study
November 9, 2020
For the full poster on the Phase 1 trial click the button below.
Published Research in Nature Communications: Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
September 10, 2020
Journal authors for the below study: Mubeen M. Mosaheb, Elena Y. Dobrikova, Michael C. Brown,…
Published Research in Science Advances: CReP mediates selective translation initiation at the endoplasmic reticulum
August 12, 2020
Journal authors for the below study: Jonathan P. Kastan, Elena Y. Dobrikova, Jeffrey D. Bryant,…
Announcing the new Istari Oncology website
August 3, 2020
Welcome to our new website; we invite you to look around. Please contact us if…
Istari Oncology Announces NEJM Publication of Phase 1 Trial Results in Patients with Recurrent Glioblastoma Treated with PVSRIPO
June 26, 2018
21% Overall Survival at 24 Months and 36 Months, Compared to 14% and 4% in…